Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Illovo Sugar Africa is the largest sugar producer in Africa and a significant manufacturer of downstream products, including pharmaceutical-grade ingredients. The company's downstream division produces lactulose, a synthetic sugar used as an active pharmaceutical ingredient (API) for treating constipation and hepatic encephalopathy. Additionally, Illovo manufactures high-quality ethyl alcohol used in medical and pharmaceutical applications. Headquartered in South Africa and owned by Associated British Foods, the company operates across six African countries, leveraging its agricultural base to supply global healthcare and industrial markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Illovo.